Shandong Longlive Bio-Technology Co., Ltd. announced earnings results for the half year ended June 30, 2019. For the half year, the company announced sales was CNY 206.764 million compared to CNY 511.999 million a year ago. Operating loss was CNY 225.843 million compared to CNY 149.933 million a year ago. Net loss was CNY 223.272 million compared to CNY 151.539 million a year ago. Basic loss per share from continuing operations was CNY 0.3724 compared to CNY 0.2528 a year ago.